Article

Glaucoma management spectrum: recent developments

Clinical research that has translated into newclinical practices in the diagnosis and treatment of glaucoma reinforcesthe importance of understanding how to assess risk in patients who are suspectedof having glaucoma or have been diagnosed with the disease. A breakfastCME symposium held Monday at the Hyatt Regency Orange County in Garden Groveincluded a panel of leading physicians who described these and other trendsin glaucoma, including the findings of several key clinical trials.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.